C.L. van der Wilt

ORCID: 0009-0008-9770-6523
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Colorectal Cancer Treatments and Studies
  • Biochemical and Molecular Research
  • Gastric Cancer Management and Outcomes
  • Cancer Treatment and Pharmacology
  • Cancer therapeutics and mechanisms
  • Cancer, Hypoxia, and Metabolism
  • Genetic factors in colorectal cancer
  • Pancreatic and Hepatic Oncology Research
  • HIV/AIDS drug development and treatment
  • Folate and B Vitamins Research
  • Cancer-related Molecular Pathways
  • Chronic Lymphocytic Leukemia Research
  • Drug Transport and Resistance Mechanisms
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Colorectal and Anal Carcinomas
  • Cancer Research and Treatments
  • Medical Imaging Techniques and Applications
  • Synthesis and biological activity
  • Quinazolinone synthesis and applications
  • Biopolymer Synthesis and Applications
  • Lung Cancer Treatments and Mutations
  • Histone Deacetylase Inhibitors Research
  • Advanced Breast Cancer Therapies
  • Sphingolipid Metabolism and Signaling
  • Metabolism, Diabetes, and Cancer

University Medical Center Utrecht
2024

Utrecht University
2024

ERN GUARD-Heart
2024

Amsterdam UMC Location Vrije Universiteit Amsterdam
1999-2008

Netherlands Comprehensive Cancer Organisation
2005

Vrije Universiteit Amsterdam
1993-2002

Novartis (Switzerland)
2001

University of Amsterdam
1991-1999

European Organisation for Research and Treatment of Cancer
1999

Norsk Hydro (Norway)
1999

PURPOSE To determine the time-dependence of fluorouracil (5FU)-induced thymidylate synthase (TS) inhibition in colon cancer patients, effect leucovorin (LV), and relation to response. PATIENTS AND METHODS A 5FU injection (500 mg/m2) was given 47 patients with advanced colorectal cancer; tumor biopsy specimens were obtained 1 72 hours after laparotomy. Eleven received LV (2-hour infusion 500 midinfusion; biopsies 45 hours. TS evaluated by comparing number total free...

10.1200/jco.1994.12.10.2035 article EN Journal of Clinical Oncology 1994-10-01

Gemcitabine (2′,2′-difluorodeoxycytidine) is a deoxycytidine analogue that activated by kinase (dCK) to its monophosphate and subsequently triphosphate dFdCTP, which incorporated into both RNA DNA, leading DNA damage. Multidrug resistance (MDR) characterised an overexpression of the membrane efflux pumps P-glycoprotein (P-gP) or multidrug resistance-associated protein (MRP). was tested against human melanoma, non-small-cell lung cancer, small-cell epidermoid carcinoma ovarian cancer cells...

10.1038/sj.bjc.6601011 article EN cc-by-nc-sa British Journal of Cancer 2003-06-01

Abstract BACKGROUND Patients with advanced cervical carcinoma are treated routinely radiotherapy and cisplatin‐containing chemotherapy. It has been shown that hyperthermia can improve the results of both cisplatin. In current study, feasibility efficacy combination all three modalities was studied in previously untreated patients carcinoma. METHODS were registered prospectively U.S., Norway, Netherlands. External‐beam brachytherapy administered for a biologically effective dose ≥ 86.7 gray....

10.1002/cncr.21128 article EN Cancer 2005-06-20

Cancer cell lines in standard culture medium or animal models are surrounded by an environment with relatively high folate (HF) levels, compared levels human plasma. In the present study we adapted 4 colon cancer (C26-A, C26-10, C26-G and WiDr) 3 squamous carcinoma of head neck (HNSCC) (11B, 14C 22B) to low (LF) (2.5, 1.0 0.5 nM, respectively) investigated whether depletion had effect on sensitivity antifolates which mechanisms were involved. All LF showed a higher 5-fluorouracil (5-FU)...

10.1002/1097-0215(20000915)87:6<771::aid-ijc2>3.0.co;2-v article EN International Journal of Cancer 2000-01-01
Coming Soon ...